The Ofev Patent Thicket: Patents expiring in 2026
With an average life expectancy of 3-5 years after diagnosis, Pulmonary fibrosis highlights an urgent need for innovative therapeutic interventions. That’s where medications like Ofev have [...]
With an average life expectancy of 3-5 years after diagnosis, Pulmonary fibrosis highlights an urgent need for innovative therapeutic interventions. That’s where medications like Ofev have [...]
Neurological disorders, ranging from Alzheimer’s disease to Parkinson’s and multiple sclerosis, present significant challenges in the medical field due to their complex nature and the [...]
Many pharmaceutical chemicals use a mix of organic solvents and plain old water. In fact, about 80% to 90% of what goes into making medicines falls into these categories. But this approach has [...]
Trajenta, known for its effective glycemic control without weight gain, is a key player in the diabetes medication sector. This critical medication, known generically as Linagliptin, is on the [...]
The European Patent Office (EPO) receives more than 2000 oppositions each year, directly impacting the future success and exclusivity of pharmaceutical products. Monitoring the outcomes of these [...]
While numerous drugs for diabetes are available in the market, many come with undesirable side effects such as weight gain, hypoglycemia, and hypertension. However, a game-changing solution has [...]
In the USA alone, almost half of the population, around 133 million people, suffer from atleast one chronic disease, and this number continues to increase. Consequently, there has been an [...]
More than 500 million people around the world are affected by diabetes, and this issue is intensified by a surging obesity crisis, particularly in wealthier nations. In such a crisis, drugs like [...]
The fiercely competitive nature of the oncology industry makes the companies invest heavily in research and development to bring in top cancer-treating drug patents. Consequently, the expiration [...]
Pembrolizumab (trade name Keytruda) is a popular drug used in cancer therapy and treatment worldwide. It is even on the World Health Organization’s (WHO) list of essential medicines. On [...]
The recent FDA controversy around Novo Nordisk’s Ozempic has brought many eyes to the drug. For the uninitiated, Ozempic (semaglutide) is an anti-obesity medication for long-term weight [...]
Closely monitoring the patent expirations of well-known branded drugs, such as Abilify for schizophrenia and Abaraxane for cancer treatment, is essential. This practice of monitoring [...]
In 2020, the FDA approved loteprednol etabonate ophthalmic suspension 0.25% (Eysuvis, Kala Pharmaceuticals Inc.) for treating dry eye disease. As one of the most common ocular surface disorders, [...]
Monitoring the drug exclusivity expiration timelines is just as important as patent expiration date when identifying opportunities and timing generic launches. Having access to detailed [...]
The study was first published on Feb 16, 2022 and then updated on Aug 16, 2023. If drug discovery is your bread and butter, you might already know that drug development often takes a decade of [...]
With companies filing for ANDAs, the global prescribed generics sales are expected to reach nearly 100 billion U.S. dollars by 2026. One example of this is Rexulti – a prescription [...]
Are you familiar with Humira? The first fully lab-made immune protein approved by the US Food and Drug Administration (FDA) for various treatments. In case you aren’t, Humira is a [...]
If Drug research and development is your bread and butter, you must be familiar with the wonders of Stelara. For the uninitiated, Stelara is the brand name of the drug Ustekinumab, which is [...]
With the explosive growth in the generic drug market, generic companies (like yours) are in a battle to claim a share of the soon-to-be-expired drugs as quickly as possible. You would want to [...]
In recent news, a woman with HIV in the United States may be the first female and third person to have been “cured” of HIV through stem cell transplants. After stem cell therapy, the woman’s HIV [...]
The complexity of the cell therapy products and patient-specific variability, product quality, and consistency are significant challenges in the Cell Therapy domain. Cell Therapy Startups with [...]
Conclusion Earlier we released a list of 91 drug patents expiring between 2020 to 2022. And while small molecule drugs still dominate the global pharmaceutical market in terms of numbers, many of [...]
Knowing the expiration date of a patent is important for multiple reasons; A key reason being that an expired patent goes into the public domain, which means everyone can now freely practice it. [...]
Jeff, a senior researcher at one of the largest chemical companies in the US, had been shouldering the burden of a problem, which, if solved could help an industry worth $43 Billion. Jeff was [...]
Genome editing or gene editing tools bring along with them a promise for a better future as they give scientists the ability to alter DNA. Further, due to the growing use of technologies for gene [...]
The cannabis industry, over the period, has dramatically adopted the minimalist mantra in the form of ‘microdosing’, aka infusing a very small amount of cannabis into various kinds of products [...]
What are the research trends our industry is following? Which competitor is building what kind of technical expertise? Are these among some of the questions that you want to get answered? Patent [...]
Why is marijuana against the law? It grows naturally upon our planet. Doesn’t the idea of making nature against the law seem to you a bit . . . unnatural? – Bill Hicks (American stand-up [...]
The Generic drugs industry is one of the fastest-growing industries of this century. Valued at USD 200 Billion in 2015, the global market for generic drugs is expected to reach USD 380 Billion by [...]
In recent months, the legal Cannabis market has emerged as a hot topic of discussion among technology enthusiasts, as the market is emerging post-haste as more and more governments are legalizing [...]
“I’m in the weed-growing business. And cousin, business is a ’boomin!” [...]
Things happen fairly slowly, you know. They do. These waves of technology, you can see them way before they happen, and you just have to choose wisely which ones you’re going to surf. If you [...]
US9320716– An apparent sword in the arsenal of Cosmo Technologies -a subsidiary of COSMO Pharmaceuticals- has been on the battlefield a lot, lately. This weapon of choice, both individually [...]
While much has been said about the need for a regular Competitor Patent Monitoring exercise in every major industry, the importance of the patent monitoring process in the Pharmaceutical [...]
Macitentan is a drug by Actelion for treating Pulmonary Arterial Hypertension (PAH). It’s popularly known as Opsumit and delays the progression of PAH, which got approval from the FDA in Dec [...]
How far have your closest competitors come? What patents? In what countries are they valid, and for how long? Or, more specifically: What has happened in your particular technological area during [...]